Accord Logo

Intended for UK patients and members of the public

PIL - Mycophenolate mofetil 500 mg powder for concentrate for solution for infusion: Change history

  • Description of update: The following change(s) has been notified:

    Type IA (B.III.1.a.2) to update the certificate of suitability from already approved supplier, Biocon from revision R1-CEP 2010-162-Rev 05 to R1-CEP 2010-162-Rev 06.

    Type IA (B.III.1.a.2) to update the certificate of suitability from already approved supplier, Biocon from revision R1-CEP 2010-162-Rev 06 to R1-CEP 2010-162-Rev 07.

    Type IA (B.III.1.a.2) to update the certificate of suitability from already approved supplier, Biocon from revision R1-CEP 2010-162-Rev 07 to CEP 2010-162-Rev 08.

    Type IA (A.7) deletion of Accord Healthcare B.V. Utrecht, Winthontlaan 200 3526 KV at Utrecht, Netherland as batch release site only.

    PIL section updated: 6 (for A.7 change).

    No changes to SmPC.

    RMS approval date: 25/04/2024.

    • Changes: (Updated: 02 May 2024)

      Description of update: The following change(s) has been notified:

      Type IA (B.III.1.a.2) to update the certificate of suitability from already approved supplier, Biocon from revision R1-CEP 2010-162-Rev 05 to R1-CEP 2010-162-Rev 06.

      Type IA (B.III.1.a.2) to update the certificate of suitability from already approved supplier, Biocon from revision R1-CEP 2010-162-Rev 06 to R1-CEP 2010-162-Rev 07.

      Type IA (B.III.1.a.2) to update the certificate of suitability from already approved supplier, Biocon from revision R1-CEP 2010-162-Rev 07 to CEP 2010-162-Rev 08.

      Type IA (A.7) deletion of Accord Healthcare B.V. Utrecht, Winthontlaan 200 3526 KV at Utrecht, Netherland as batch release site only.

      PIL section updated: 6 (for A.7 change).

      No changes to SmPC.

      RMS approval date: 25/04/2024.

    • Changes: (Updated: 21 Sep 2022)

      Initial upload

    View product information as a: